What is a stock summary page? Click here for an overview.
Business Description

Entheon Biomedical Corp
NAICS : 325412
SIC : 3741
ISIN : CA29383X1033
Share Class Description:
ENTBF: Ordinary SharesDescription
Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 69.5 | |||||
3-Year EPS without NRI Growth Rate | 70.4 | |||||
3-Year FCF Growth Rate | 64.8 | |||||
3-Year Book Growth Rate | -78.1 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.39 | |||||
9-Day RSI | 41 | |||||
14-Day RSI | 39.77 | |||||
3-1 Month Momentum % | 18.62 | |||||
6-1 Month Momentum % | 89.47 | |||||
12-1 Month Momentum % | 87.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.59 | |||||
Quick Ratio | 10.59 | |||||
Cash Ratio | 8 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.5 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -130.2 | |||||
ROA % | -109.1 | |||||
ROIC % | -3192.31 | |||||
3-Year ROIIC % | -113.1 | |||||
ROC (Joel Greenblatt) % | -1443.48 | |||||
ROCE % | -133.12 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 8.89 | |||||
Price-to-Tangible-Book | 8.89 | |||||
EV-to-EBIT | -4.56 | |||||
EV-to-EBITDA | -4.56 | |||||
EV-to-FCF | -5.26 | |||||
Price-to-Net-Current-Asset-Value | 8.89 | |||||
Price-to-Net-Cash | 8.89 | |||||
Earnings Yield (Greenblatt) % | -21.93 | |||||
FCF Yield % | -21.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ENTBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Entheon Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.026 | ||
Beta | 2.8 | ||
3-Year Sharpe Ratio | -0.05 | ||
3-Year Sortino Ratio | -0.09 | ||
Volatility % | 137.12 | ||
14-Day RSI | 39.77 | ||
14-Day ATR ($) | 0.009634 | ||
20-Day SMA ($) | 0.09534 | ||
12-1 Month Momentum % | 87.26 | ||
52-Week Range ($) | 0.0225 - 0.288 | ||
Shares Outstanding (Mil) | 13.86 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Entheon Biomedical Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Entheon Biomedical Corp Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Entheon Biomedical Corp Frequently Asked Questions
What is Entheon Biomedical Corp(ENTBF)'s stock price today?
The current price of ENTBF is $0.09. The 52 week high of ENTBF is $0.29 and 52 week low is $0.02.
When is next earnings date of Entheon Biomedical Corp(ENTBF)?
The next earnings date of Entheon Biomedical Corp(ENTBF) is .
Does Entheon Biomedical Corp(ENTBF) pay dividends? If so, how much?
Entheon Biomedical Corp(ENTBF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |